Aptose Biosciences (APTO) Stock Chart & Stock Price History → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free APTO Stock Alerts $1.13 +0.02 (+1.80%) (As of 05/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Aptose Biosciences Stock Price Performance5 Day Performance+4.63%1 Month Performance-7.38%3 Month Performance-38.92%6 Month Performance-49.33%Year-To-Date Performance-55.51%1 Year Performance-82.06% Receive APTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. APTO Stock Chart for Tuesday, May, 28, 2024 APTO Chart by TradingView Aptose Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/28/2024$1.11$1.13+1.80%$1.19$1.1146,557 shs$18.41 million05/27/2024$1.11$1.11$1.13$1.0830,300 shs$18.08 million05/24/2024$1.08$1.11+2.78%$1.13$1.0830,330 shs$18.08 million05/23/2024$1.13$1.08-4.42%$1.16$1.0662,127 shs$17.59 million05/22/2024$1.15$1.13-1.74%$1.16$1.1062,944 shs$18.41 million05/21/2024$1.15$1.15$1.17$1.1162,438 shs$18.73 million Get the Latest News and Ratings for APTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. 05/20/2024$1.18$1.15-2.54%$1.20$1.1436,119 shs$18.73 million05/17/2024$1.19$1.15-3.36%$1.21$1.15107,763 shs$18.73 million05/16/2024$1.21$1.19-1.65%$1.21$1.1819,956 shs$19.39 million05/15/2024$1.23$1.21-1.63%$1.25$1.1842,814 shs$19.71 million05/14/2024$1.18$1.23+4.24%$1.24$1.1784,029 shs$20.04 million05/13/2024$1.23$1.18-4.07%$1.25$1.17146,262 shs$19.22 million05/10/2024$1.24$1.23-0.81%$1.26$1.2216,430 shs$19.33 million05/09/2024$1.23$1.24+0.81%$1.24$1.2217,890 shs$19.49 million05/08/2024$1.23$1.23$1.27$1.1825,039 shs$19.33 million05/07/2024$1.21$1.23+1.65%$1.25$1.2135,616 shs$19.34 million05/06/2024$1.20$1.21+0.83%$1.24$1.2092,162 shs$19.02 million05/03/2024$1.19$1.20+0.84%$1.23$1.1930,874 shs$18.70 million05/02/2024$1.21$1.19-1.65%$1.21$1.1932,307 shs$18.71 million05/01/2024$1.20$1.21+0.83%$1.23$1.1934,373 shs$19.02 million04/30/2024$1.23$1.20-2.44%$1.24$1.2038,099 shs$18.86 million04/29/2024$1.22$1.23+0.82%$1.25$1.1852,084 shs$19.34 million04/26/2024$1.16$1.22+5.17%$1.27$1.16104,863 shs$19.18 million04/25/2024$1.22$1.16-4.92%$1.24$1.1547,086 shs$18.24 million04/24/2024$1.23$1.22-0.81%$1.26$1.2056,221 shs$19.18 million04/23/2024$1.23$1.23$1.28$1.2072,321 shs$19.34 million04/22/2024$1.23$1.23-0.08%$1.26$1.2111,944 shs$19.34 million04/19/2024$1.27$1.23-3.15%$1.29$1.2336,438 shs$19.96 million04/18/2024$1.26$1.27+0.79%$1.29$1.2534,123 shs$19.96 million04/17/2024$1.27$1.26-0.79%$1.34$1.2631,324 shs$19.81 million04/16/2024$1.30$1.27-2.31%$1.32$1.2045,647 shs$19.96 million04/15/2024$1.36$1.30-4.41%$1.39$1.2964,914 shs$20.44 million04/12/2024$1.38$1.36-1.45%$1.42$1.3435,177 shs$21.38 million04/11/2024$1.38$1.38$1.43$1.3751,170 shs$21.69 million04/10/2024$1.41$1.38-2.13%$1.48$1.3853,917 shs$21.69 million04/09/2024$1.47$1.41-4.08%$1.49$1.40169,377 shs$22.17 million04/08/2024$1.38$1.47+6.52%$1.52$1.38113,180 shs$23.11 million04/05/2024$1.43$1.38-3.50%$1.47$1.3855,838 shs$21.69 million04/04/2024$1.44$1.43-0.69%$1.56$1.39134,393 shs$22.48 million04/03/2024$1.58$1.44-8.86%$1.58$1.44113,190 shs$22.64 millionTruth about Trump you’ve never heard (Ad)Everything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. For the full story, click here.04/02/2024$1.60$1.58-1.25%$1.67$1.51101,097 shs$24.84 million04/01/2024$1.66$1.60-3.61%$1.72$1.53122,551 shs$25.15 million03/29/2024$1.66$1.66$1.70$1.50137,093 shs$26.10 million03/28/2024$1.50$1.66+10.67%$1.70$1.50136,730 shs$26.10 million03/27/2024$1.60$1.50-6.25%$1.54$1.4677,960 shs$23.58 million03/26/2024$1.51$1.60+5.96%$1.60$1.4850,501 shs$25.15 million03/25/2024$1.55$1.51-2.58%$1.61$1.4953,463 shs$23.73 million03/22/2024$1.57$1.55-1.27%$1.62$1.5086,936 shs$24.37 million03/21/2024$1.52$1.57+3.29%$1.58$1.4741,965 shs$24.68 million03/20/2024$1.50$1.52+1.33%$1.52$1.4617,556 shs$23.88 million03/19/2024$1.50$1.50$1.59$1.40148,279 shs$23.57 million03/18/2024$1.52$1.50-1.32%$1.54$1.4740,035 shs$23.57 million03/15/2024$1.40$1.52+8.57%$1.52$1.3770,156 shs$23.88 million03/14/2024$1.44$1.40-2.78%$1.47$1.3658,776 shs$21.99 million03/13/2024$1.50$1.44-4.00%$1.53$1.4273,376 shs$22.62 million03/12/2024$1.58$1.50-5.06%$1.60$1.4853,938 shs$23.57 million03/11/2024$1.63$1.58-3.07%$1.69$1.5377,999 shs$24.82 million03/08/2024$1.68$1.63-2.98%$1.74$1.57111,797 shs$25.61 million03/07/2024$1.67$1.68+0.60%$1.70$1.6530,135 shs$26.39 million03/06/2024$1.76$1.67-5.11%$1.82$1.60106,663 shs$26.23 million03/05/2024$1.81$1.76-2.76%$1.83$1.72115,513 shs$27.65 million03/04/2024$1.87$1.81-3.21%$1.87$1.75102,625 shs$28.44 million03/01/2024$1.80$1.87+3.89%$1.87$1.7553,909 shs$28.27 million02/29/2024$1.85$1.80-2.70%$1.90$1.74112,341 shs$28.28 million02/28/2024$1.90$1.85-2.63%$1.94$1.7685,440 shs$29.06 million02/27/2024$1.90$1.90$1.94$1.8591,581 shs$29.85 million Related Companies: Evaxion Biotech A/S Stock Chart PharmaCyte Biotech Stock Chart Senti Biosciences Stock Chart AIM ImmunoTech Stock Chart Tevogen Bio Stock Chart Coeptis Therapeutics Stock Chart Inhibikase Therapeutics Stock Chart Cortexyme Stock Chart BioCardia Stock Chart Chromocell Therapeutics Stock Chart Receive APTO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APTO) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesHe Is Giving Away BitcoinCrypto Swap ProfitsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.